Mammographic surveillance in women aged 35-39 at enhanced familial risk of breast cancer (FH02)

Familial Cancer

Volumn 13, Issue 1, 2014, Pages 13-21

  Evans, D G ^a,b   Thomas, S ^c   Caunt, J ^c   Roberts, L ^a   Howell, A ^a,b   Wilson, M ^a   Fox, R ^c   Sibbering, D M ^d   Moss, S ^e   Wallis, M G ^f   Eccles, D M ^g   Duffy, S ^e   Waldron, Eleanor ^h   Smart, Lesley ⁱ   Luke, Lynda ⁱ   Rai, Simerjit ^j   Linforth, Richard ^j   Stevens, Guy ^k,l,m   Evans, Jane ^k,l,m   Luft, Nick ⁿ   Devlin, Hollie ^j   Farnon, Cathy ^o   Hall, Ruth ^o   Chorley, Wendy ^j   Mayor, Diana ^j   Salih, Vian ^j   Potdar, N ^p,t   Modi, A ^p   Hunter, Joy ^q   Rashed, Mohammed ^j   Turton, Philip ^j   Hartup, Sue ^j   Barwell, Julian ^j   Hale, Tracey ^r   Henderson, Alex ^j   Jobson, Irene ^j   Teh, William ^s   Macmillan, R D ^j   Anand, Ambika ^t   Sheppard, Carmel ^j   Di Cameron, ^u   Davies, Mary ^u   Holcombe, Sue ^v   Francis, Laura ^v   Gui, Gerald ^w   Self, Janet ^w   Dalgliesh, Diana ^x   Knight, Katherine ^x   Rothnie, Neil ^j   Christensen, D ^j   Newell, Janet ^j   McFerran, Ethna ^j   Greenhalgh, Rosemary ^a   Affen, Jenny ^a   Lewis, Celia ^y   Audisio, Riccardo ^z   more..

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Breast Test Wales   (United Kingdom)

^d ROYAL DERBY HOSPITAL   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^h Airedale NHS Trust   (United Kingdom)

ⁱ Ardmillan Screening Centre   (United Kingdom)

^j BTW Cardiff ^*

^k BTW Cardiff   (United Kingdom)

^l BTW Llandudno   (United Kingdom)

^m BTW Singleton   (United Kingdom)

ⁿ QUEEN S HOSPITAL   (United Kingdom)

^o CRAIGAVON AREA HOSPITAL   (United Kingdom)

^p United Lincolnshire Hospitals NHS Trust   (United Kingdom)

^q HOPE HOSPITAL   (United Kingdom)

^r LEIGHTON HOSPITAL   (United Kingdom)

^s NORTHWICK PARK HOSPITAL   (United Kingdom)

^t PILGRIM HOSPITAL   (United Kingdom)

^u Royal Devon and Exeter   (United Kingdom)

^v ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^w ROYAL MARSDEN HOSPITAL   (United Kingdom)

^x ROYAL UNITED HOSPITAL   (United Kingdom)

^y UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^z WHISTON HOSPITAL   (United Kingdom)

more..

Author keywords

BRCA1; BRCA2; Breast cancer; High risk; Mammography; MRI; Screening

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIGITAL MAMMOGRAPHY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LIFESPAN; LYMPH NODE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TUMOR VOLUME; BREAST NEOPLASMS; CLINICAL TRIAL; GENETIC PREDISPOSITION; MAMMOGRAPHY; MASS SCREENING; MULTICENTER STUDY; PATHOLOGY; RADIOGRAPHY; RISK FACTOR; UNITED KINGDOM;

ADULT; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; MAMMOGRAPHY; MASS SCREENING; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84896709916     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-013-9661-8     Document Type: Article

References (28)

1. McIntosh A, Shaw C, Evans G, et al (2006) Clinical guidelines and evidence review for the classification and care of women at risk of familial breast cancer, National Collaborating Centre for Primary Care/University of Sheffield, London. NICE guideline CG041. www.nice.org.uk
2. Mackay J, Rogers C, Fielder H et al (2001) Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer. J Epidemiol Biostat 6:365-369 (Pubitemid 33134093)
3. FH01 management committee, steering committee and collaborators (2006) The challenge of evaluating annual mammography screening for young women with a family history of breast cancer. J Med Screen 13:177-182
4. FH01 collaborative teams (2010) Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncol 11:1127-1134
5. Wald NJ, Murphy P, Major P et al (1995) UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. BMJ 311:1189-1193
6. Pisano ED, Gatsonis C, Hendrick E et al (2005) Diagnostic performance of digital versus film mammography for breast cancer screening. N Engl J Med 353:1773-1783 (Pubitemid 41549889)
7. Leach MO, Boggis CR, Dixon AK et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769-1778 (Pubitemid 40744657)
8. Gilbert FJ, Astley SM, Gillan MG et al (2008) Single reading with computer aided detection for screening mammography. N Engl J Med 359:1675-1684
9. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L, Trial Management Group (2006) Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 368:2053-2060 (Pubitemid 44855105)
10. Law J, Faulkner K, Young KC (2007) Risk factors for induction of breast cancer by X-rays and their implications for breast screening. Br J Radiol 80(952):261-266 (Pubitemid 47022817)
11. Maurice A, Evans DGR, Shenton A, Boggis C, Wilson M, Duffy S, Howell A (2006) The screening of women aged less than 50 years at increased risk of breast cancer by virtue of their family history. Eur J Cancer 42:1385-1390
12. Maurice A, Evans DG, Affen J, Greenhalgh R, Duffy SW, Howell A (2012) Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: further evidence of benefit. Int J Cancer 131:417-425
13. Eccles D, Gerty S, Simmonds P, Hammond V, Ennis S, Altman DG, POSH steering group (2007) Prospective study of outcomes in sporadic versus hereditary breast cancer (POSH): study protocol. BMC Cancer 7:160
14. Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early onset breast cancer. Cancer 73:643-651
15. Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23:1111-1130 (Pubitemid 38477070)
16. Amir E, Evans DG, Shenton A et al (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40:807-814 (Pubitemid 37485490)
17. Eccles DM, Evans DGR, Mackay J (2000) Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. J Med Genet 37:203-209 (Pubitemid 30245915)
18. Pharoah P, Day NE, Duffy S et al (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71:800-809 (Pubitemid 27237202)
19. Day NE, Walter SD (1984) Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 43:1-13
20. Day N, McCann J, Camilleri-Ferrante C et al (1995) Monitoring interval cancers in breast screening programmes: the east Anglian experience. Quality assurance management group of the east anglian breast screening programme. Med Screen 2:180-185
21. Paci E, Warwick J, Falini P, Duffy SW (2004) Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen 11:23-27 (Pubitemid 38365691)
22. Brain K, Henderson BJ, Tyndel S, Bankhead C, Watson E, Clements A, Austoker J, PIMMS Study Management Group (2008) Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme. Psychooncology 17:1180-1188
23. Moss S, Waller M, Anderson TJ, Cuckle H, Trial Management Group (2005) Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures. Br J Cancer. 92:955-960 (Pubitemid 40462645)
24. Bjurstam N, Bjorneld L, Duffy SW et al (1997) The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer 80:2091-2099 (Pubitemid 27506022)
25. Paci E, Duffy SW (1991) Modelling the analysis of breast cancer screening programmes: sensitivity, lead time and predictive value in the Florence District Programme (1975-1986). Int J Epidemiol 20:852-858
26. Norman RP, Evans DG, Easton DF, Young KC (2007) The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30-49. Eur J Health Econ 8: 137-144 (Pubitemid 46742897)
27. Taylor L, Basro S, Apffelstaedt JP, Baatjes K (2011) Time for a re-evaluation of mammography in the young? Results of an audit of mammography in women younger than 40 in a resource restricted environment. Breast Cancer Res Treat 129:99-106
28. Hellquist BN, Duffy SW, Nyström L, Jonsson H (2012) Over-diagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden. J Med Screen 19:14-19